Our Research

Scientific research has been at the heart of every breakthrough we’ve made in the fight against HIV and in order to stop HIV we need convenient, safe, and effective prevention options. As we search for innovative solutions to guide HIV prevention, we continue to conduct clinical trials of promising strategies to understand their effectiveness and safety across different populations at risk for HIV infection.

Groundbreaking research—the kind we need for HIV—must include diverse participants from all parts of the community. Although many research projects lack critical community voices, HelpFightHIV.org and Bridge HIV are committed to inclusive research studies. We must be at the table to make sure we are served well! Our fight against HIV is focused on achieving health equity for all so our research must be too.

Our innovative research is focused on helping fight HIV through several strategies, so whether it’s an HIV vaccine, a new way to do HIV testing or a new pill to prevent HIV, the goal is the same.

But, we need your help. Check out our current studies below and volunteer today!

We are currently enrolling the following studies:

 

We are often recruiting for various phase 1 HIV vaccine and antibody infusion studies, which are a critical part of the pathway to finding an effective vaccine against HIV. These studies involve a small number of people who have lower risk of HIV infection based on their sexual activities or use of PrEP. The main purpose of phase 1 studies is to test the safety of the product, and to see if it causes an immune response.

Participation in a phase 1 study are specific to each study but might include:

  • Giving urine, blood, and/or other samples.
  • Receiving an investigational vaccine or antibody infusion.
  • Visits to our clinic for 1-2 years.
  • Keeping a diary for several days after injection or infusion visits.
  • Regular contact with study clinicians.
  • Regular physical exams.
  • Answering questionnaires.

You may be eligible for a phase 1 study if you are:

  • Between 18-50 years old, HIV negative, and in general good health.
  • People who are taking PrEP may also be eligible for these studies.

Eligible participants will receive up to $125 per visit for their time and travel.

Send us a note using the form below and we’ll ring you back to see if you’re eligible for the study. It’s that simple!

Contact me

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    Learn more about how we use the information you provide to us in our Privacy Policy.



     

    The PrEP-3D study will pilot an online PrEP delivery service using Alto Pharmacy. Participation in the study involves downloading the Alto Pharmacy app to your phone and using their services to get your PrEP delivered to your home.

    Participants must be willing to participate in the study for 12 months and complete home STI/HIV tests and online surveys. All study visits can take place online or remotely.

    If eligible to participate, we will help you get PrEP. Some participants will also get access to the Alto Pharmacy app, which will allow them to get PrEP delivered to them.

    You may be eligible to participate if:

    • You are 18 years or older,
    • are HIV negative,
    • are a cisgender man who has sex with other men,
    • are a California resident,
    • own a smartphone,
    • and are willing to get your PrEP delivered through Alto Pharmacy.

    You will not be eligible If you are insured through Kaiser or health Plan of San Mateo.

    Eligible participants can receive up to $550 if they complete all study procedures.

    Send us a note using the form below and we’ll ring you back to see if you’re eligible for the study. It’s that simple!

    Contact me

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
      Learn more about how we use the information you provide to us in our Privacy Policy.



       

      The I Am Study is exploring the impact of offering Pre-exposure Prophylaxis (PrEP) access and services along with gender affirming services and peer Health Navigation – all in the same place and at the same time.

      The study will enroll HIV-negative transgender women, who are at least 18 years of age, and are interested in Pre-exposure Prophylaxis (PrEP) to prevent HIV infection.

      Participation involves receiving PrEP, STI screening and treatment, co-located gender affirming services and Peer Health Navigation using Strengths-Based Case Management for 18 months.

      For their time and travel, eligible participants can receive up to $125 per visit.

      Send us a note using the form below and we’ll ring you back to see if you’re eligible for the study. It’s that simple!

      Contact me

        This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
        Learn more about how we use the information you provide to us in our Privacy Policy.



        Active studies related to HIV cure science (including therapeutic vaccines) are conducted by our AIDS Clinical Trials Group (ACTG) partners at the Positive Health Program at the University of California, San Francisco.

        Their studies range from strategies to address HIV-associated inflammation, innovative antiretroviral therapy treatment including regimen simplification / injectable medications, and optimization of treatment for complications related to co-infections. In addition, they have active research in tuberculosis and viral hepatitis (both hepatitis B and C) for people living with or without HIV.

        For more information about actively enrolling studies, please call or text Dan Berrner at (415) 535-9495 or email him at daniel.berrner@ucsf.edu.


        helpfighthiv.org